AI Article Synopsis
- Familial hypercholesterolemia (FH) is a genetic disorder leading to high LDL-cholesterol, increasing risks of cardiovascular issues later in life, particularly in adults.
- A study tested 20 Romanian children with elevated LDL-cholesterol levels at a specialized health institute, using the Illumina TruSight Cardio panel for genetic analysis.
- Results showed that 5 out of 20 patients had identifiable pathogenic genetic variants linked to FH, indicating that early diagnosis through lipid screening could be crucial for prevention.
Article Abstract
Familial hypercholesterolemia (FH) is a genetic disease marked by high levels of LDL-cholesterol. This condition has long-term clinical implications, such as cardiovascular events, that are evident during adult life. Here, we report on a single-center cross-sectional showcase study of genetic testing for FH in a Romanian pediatric group. Genetic testing for FH was performed on 20 Romanian pediatric patients, 10 boys and 10 girls, admitted with LDL-cholesterol levels over 130 mg/mL to the National Institute for Mother and Child Health "Alesssandrescu-Rusescu" in 2020. Genetic testing was performed using the Illumina TruSight Cardio panel. We identified pathogenic/likely pathogenic variants that could explain the phenotype in 5/20 cases. The involved genes were and . Clinical signs that suggest the diagnosis of FH are scarce for the pediatric patient, although it can be diagnosed early during childhood by lipid panel screening. Prevention could prove lifesaving for some of these patients.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10296998 | PMC |
| http://dx.doi.org/10.3390/diagnostics13121988 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!